Q32 Bio Inc.Q32 Bio Inc.Q32 Bio Inc.

Q32 Bio Inc.

No trades
No trades

Compare with Q32 Bio Inc.


Market capitalization
‪381.05 M‬USD
3.01USD
‪29.82 M‬USD
‪53.74 M‬USD
‪21.00 M‬
Beta (1Y)
−2.16
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
24
Change (1Y)
−18−42.86%
Revenue / Employee (1Y)
‪2.24 M‬USD
Net income / Employee (1Y)
‪1.24 M‬USD

Company info


CEO
Jodie P. Morrison
Website
Headquarters
Waltham
Founded
2017
IPO date
Mar 28, 2018
ISIN
US7469641051
CUSIP
746964105
FIGI
BBG00CTTJWQ9
Identifiers
ISIN US7469641051
CFI code
ESVUFR
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Weight0.02%
Market value‪6.73 M‬
Weight0.20%
Market value‪553.85 K‬
Weight0.03%
Market value‪374.67 K‬
Weight0.53%
Market value‪121.53 K‬
Weight0.08%
Market value‪15.31 K‬

Explore more ETFs 

Frequently asked questions


The current price of QTTB is 11.99 USD — it has decreased by −6.33% in the past 24 hours. Watch Q32 Bio Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Q32 Bio Inc. stocks are traded under the ticker QTTB.
QTTB stock has fallen by −24.64% compared to the previous week, the month change is a −25.76% fall, over the last year Q32 Bio Inc. has showed a 589.08% increase.
We've gathered analysts' opinions on Q32 Bio Inc. future price: according to them, QTTB price has a max estimate of 59.00 USD and a min estimate of 34.00 USD. Watch QTTB chart and read a more detailed Q32 Bio Inc. stock forecast: see what analysts think of Q32 Bio Inc. and suggest that you do with its stocks.
QTTB reached its all-time high on Feb 27, 2019 with the price of 572.40 USD, and its all-time low was 1.35 USD and was reached on Jul 7, 2025. View more price dynamics on QTTB chart.
See other stocks reaching their highest and lowest prices.
QTTB stock is 11.30% volatile and has beta coefficient of −2.16. Track Q32 Bio Inc. stock price on the chart and check out the list of the most volatile stocks — is Q32 Bio Inc. there?
Today Q32 Bio Inc. has the market capitalization of ‪356.94 M‬, it has decreased by −11.25% over the last week.
Yes, you can track Q32 Bio Inc. financials in yearly and quarterly reports right on TradingView.
Q32 Bio Inc. is going to release the next earnings report on Nov 5, 2026. Keep track of upcoming events with our Earnings Calendar.
QTTB earnings for the last quarter are −0.44 USD per share, whereas the estimation was −0.46 USD resulting in a 4.34% surprise. The estimated earnings for the next quarter are −0.32 USD per share. See more details about Q32 Bio Inc. earnings.
Q32 Bio Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of ‪750.00 K‬ USD. In the next quarter, revenue is expected to reach 0.00 USD.
QTTB net income for the last quarter is ‪−8.95 M‬ USD, while the quarter before that showed ‪−7.61 M‬ USD of net income which accounts for 0.00% change. Track more Q32 Bio Inc. financial stats to get the full picture.
No, QTTB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 5, 2026, the company has 24 employees. See our rating of the largest employees — is Q32 Bio Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Q32 Bio Inc. EBITDA is ‪21.82 M‬ USD, and current EBITDA margin is 32.18%. See more stats in Q32 Bio Inc. financial statements.
Like other stocks, QTTB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Q32 Bio Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Q32 Bio Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Q32 Bio Inc. stock shows the sell signal. See more of Q32 Bio Inc. technicals for a more comprehensive analysis.